{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-067689","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.615022+00:00","generated_at":"2026-05-31T10:06:34.148210+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vicarious Surgical Q2 net loss $15.2M; cash burn $10.9M, reiterates FY2024 ~$50M","bullets":["GAAP net loss $15.2M ($2.59/sh) vs $15.3M ($3.62/sh) in Q2 2023; adjusted net loss $16.8M ($2.86/sh).","Operating expenses $17.7M, down 17% YoY; R&D $10.9M, G&A $5.6M, S&M $1.2M.","Cash and investments $73.2M as of June 30, 2024; Q2 2024 cash burn $10.9M.","Reaffirmed full-year 2024 cash burn guidance of approximately $50 million.","Partnered with LSU Health New Orleans as fifth U.S. hospital system; V1.0 integration milestone on track for fall 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-067689","json":"https://secwatch.observer/filing/0001213900-24-067689.json","markdown":"https://secwatch.observer/filing/0001213900-24-067689.md","text":"https://secwatch.observer/filing/0001213900-24-067689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024067689/0001213900-24-067689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024067689/ea0210959-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:06:34.148210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}